drugset / Trial / NCT01646307
Effect of Atorvastatin Versus Rosuvastatin Intensive Statin Regimens on Chinese Elderly Patients Undergoing PCI
RandomizedParallel-groupOpen-labelTreatment
Summary
This randomized, open label, parallel-group study is designed to investigate whether periprocedural intensive statin therapy with atorvastatin versus rosuvastatin administration before PCI and 30-day continuous intensive treatment is superior to usual care, in terms of cardiovascular events for Chinese elderly patients.
Timeline
- Start
- 2012-01
- Primary completion
- 2013-01
- Completion
- 2013-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Atorvastatin | Small molecule | 20 mg | — |
| Comparator | Atorvastatin | Small molecule | 40 mg | — |
| Comparator | Rosuvastatin | Small molecule | 10 mg | — |
Indications
No indication recorded.